SCHEMBL25535180

SCHEMBL25535180

c1ccc(-c2cc(-c3ccccc3-c3ccccc3)nc(-c3ccc(-c4ccc5c(c4)-c4ccccc4C5(c4ccccc4)c4ccccc4)c4ccccc34)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.37
MEN1 O00255 7/20 0.37
KMT2A Q03164 7/20 0.37
ALDH1A1 P00352 5/20 0.37
HPGD P15428 5/20 0.37
LMNA P02545 4/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
KDM4E B2RXH2 4/20 0.35
OPRK1 P41145 1/20 0.35
NTSR1 P30989 1/20 0.34
AGTR1 P30556 3/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
CYP3A4 P08684 1/20 0.34
GAA P10253 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
ACACA Q13085 1/20 0.34
TDP1 Q9NUW8 2/20 0.33
GLA P06280 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25534896 0.95 MAPT (0.35) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL25535182 0.95 MEN1 (0.40) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL25535189 0.94 MEN1 (0.39) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL25535216 0.93 MEN1 (0.38) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL25540625 0.92 MAPT (0.35) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL25535218 0.92 ENPP1 (0.38) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL25534967 0.92 MEN1 (0.38) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL25535179 0.91 CHRNA1 (0.35) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL25534970 0.91 MEN1 (0.44) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL25534877 0.90 MEN1 (0.39) MAPTMEN1KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM MAPT 1595/4885MEN1 267/4885KMT2A 1094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.